Back
LivaNova Plc 10K Form
Buy
60
LIVN
LivaNova Plc
Last Price:
$63.38
Seasonality Move:
9.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | LIVN/LivaNova Plc Quarterly |
| 2023-07-26 | 10Q | LIVN/LivaNova Plc Quarterly |
| 2023-05-03 | 10Q | LIVN/LivaNova Plc Quarterly |
| 2022-11-02 | 10Q | LIVN/LivaNova Plc Quarterly |
| 2022-08-03 | 10Q | LIVN/LivaNova Plc Quarterly |
| 2022-05-04 | 10Q | LIVN/LivaNova Plc Quarterly |
Receive LIVN News And Ratings
See the #1 stock for the next 7 days that we like better than LIVN
LIVN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $62.2M |
| Price / Cash Flow: | 18.27 |
| Annual Sales: | $21.19 |
| Price / Book: | 3.02 |
Profitability
| EPS (TTM): | -4.01060 |
|---|---|
| Net Income (TTM): | $-217.5M |
| Gross Margin: | $872.2M |
| Return on Equity: | -18.29% |
| Return on Assets: | -8.6% |
LivaNova Plc Earnings Forecast
Key LivaNova Plc Financial Ratios
-
The Gross Profit Margin over the past 32 years for LIVN is 69.58%.
-
The Selling, General & Administrative Expenses for LIVN have been equal to 41.99% of Gross Profit Margin.
-
The Research & Development expenses have been 14.40% of Revenue.
-
The Interest Expense is 99.74% of Operating Income.
-
The Net Earning history of LIVN is 5.04% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 19 years.
LivaNova Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LIVN |
| CUSIP: | G5509L |
| Website: | livanova.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 1.33 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 55.15 |
|---|---|
| Forward P/E Ratio: | 15.45 |
LIVN Technical Analysis vs Fundamental Analysis
Buy
60
LivaNova Plc (LIVN)
is a Buy
Is LivaNova Plc a Buy or a Sell?
-
LivaNova Plc stock is rated a BuyThe current LivaNova Plc [LIVN] share price is $63.90. The Score for LIVN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.